Keyphrases
Asenapine
100%
Monoamines
100%
Subchronic
100%
Phencyclidine
100%
Monkey
78%
Brain Regions
42%
Serotonin Turnover
35%
Dopamine Turnover
35%
Dopamine
21%
Twice Daily
21%
Serotonin
21%
Cognitive Dysfunction
21%
Reversal Learning
21%
Schizophrenia
14%
Executive Function
14%
Cognitive Deficits
14%
Cognitive Function
14%
Prefrontal Cortex
14%
Atypical Antipsychotics
14%
Bipolar Disorder
7%
Acute Manic Episode
7%
Mixed Episodes
7%
Learning Performance
7%
Adjunctive Therapy
7%
Monotherapy
7%
Nucleus Accumbens
7%
Long-term Administration
7%
Neurochemicals
7%
Neurotransmission
7%
Schizophrenia Treatment
7%
Dysregulation
7%
Patients with Schizophrenia
7%
Amines
7%
Schizophrenia Symptoms
7%
Bipolar I Disorder
7%
Intermittent Administration
7%
Motor Function
7%
Steady State
7%
Serotonergic System
7%
Lithium
7%
Laboratory Animals
7%
Major Metabolites
7%
Treatment Impact
7%
Central Amygdala
7%
Fine Motor Skills
7%
Ultra-high Performance Liquid Chromatography (UHPLC)
7%
Saline Control
7%
Function Modeling
7%
Enhancement Effect
7%
Neurochemical Changes
7%
Valproate
7%
Orbitofrontal Cortex
7%
NMDA Antagonist
7%
Dopamine Depletion
7%
Noradrenergic Receptors
7%
Reversal Learning Task
7%
Retrieval Methods
7%
Object Retrieval
7%
Receptor-binding Properties
7%
Pharmacology, Toxicology and Pharmaceutical Science
Asenapine
100%
Monoamine
100%
Phencyclidine
100%
Haplorhini
78%
Serotonin
57%
Cognitive Defect
35%
Atypical Antipsychotics
14%
Experimental Animal
7%
Sodium Valproate
7%
Serotonin Receptor
7%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
7%
Psychotropic Agent
7%
Hyperbarism
7%
Alpha Adrenergic Receptor
7%
Monotherapy
7%
Mixed Anxiety and Depression
7%
Bipolar Disorder
7%
Bipolar I Disorder
7%
Mania
7%
Neuroscience
Asenapine
100%
Phencyclidine
100%
Monoamine
100%
Serotonin
57%
Cognitive Disorders
35%
Dementia Praecox
21%
Prefrontal Cortex
14%
Atypical Antipsychotic
14%
Executive Functions
14%
Bipolar Disorder
7%
Receptor Binding
7%
Amygdala
7%
Nucleus Accumbens
7%
Orbitofrontal Cortex
7%
Treatment of Schizophrenia
7%
5-HT Receptor
7%
Bipolar I Disorder
7%
Neurotransmission
7%
Mania
7%
Alpha Adrenergic Receptor
7%
Adjuvant Therapy
7%
NMDA Receptor Antagonist
7%
Typical Antipsychotic
7%
Mixed Anxiety and Depression
7%
Psychoactive Drug
7%